ResearcherVilnius UniversityActive in the last 2 years
Aistė Gulla
Matched on ORCID iD 0000-0003-2433-3603; OpenAlex author ID A5075856590. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 45
2021: 1 paper · 2022: 2 papers · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 6
- Survival Impact After Resection for Postoperative Recurrence or Metastasis of Pancreatic Ductal Adenocarcinoma Analyzed Using a Time-Dependent Cox Regression M… Co-author DOI 10.1002/jhbp.70054↗
- Biomarkers for Early Detection of Pancreatic Cancer. Co-author DOI 10.1159/000546584↗
- Is surgical resection justified for pancreatic ductal adenocarcinoma with distant abdominal organ metastasis? A position paper by experts in pancreatic surgery… Co-author DOI 10.1016/j.pan.2023.07.005↗
- The Impact of Epithelial-Mesenchymal Transition and Metformin on Pancreatic Cancer Chemoresistance: A Pathway towards Individualized Therapy. Co-author DOI 10.3390/medicina58040467↗
- Interdisciplinary Approach of Establishing PDAC Resectability: Biochemical, Radiological and NAT Regimen Prognostic Factors-Literature Review. Co-author DOI 10.3390/medicina58060756↗
- Heat Shock Protein 90 Inhibitor Effects on Pancreatic Cancer Cell Cultures. Co-author DOI 10.1097/mpa.0000000000001807↗
Closest collaborators
The 25 strongest of 45 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Sohei Satoi · 3 shared papers, 2022–2026 · strength 0.52
- Paper Survival Impact After Resection for Postoperative Recurrence or Metastasis of Pancreatic Ductal Adenocarcinoma Analyzed… DOI 10.1002/jhbp.70054↗
- Paper Interdisciplinary Approach of Establishing PDAC Resectability: Biochemical, Radiological and NAT Regimen Prognostic Fac… DOI 10.3390/medicina58060756↗
- Paper Is surgical resection justified for pancreatic ductal adenocarcinoma with distant abdominal organ metastasis? A positio… DOI 10.1016/j.pan.2023.07.005↗
- Daisuke Hashimoto · 3 shared papers, 2022–2026 · strength 0.52
- Paper Survival Impact After Resection for Postoperative Recurrence or Metastasis of Pancreatic Ductal Adenocarcinoma Analyzed… DOI 10.1002/jhbp.70054↗
- Paper Interdisciplinary Approach of Establishing PDAC Resectability: Biochemical, Radiological and NAT Regimen Prognostic Fac… DOI 10.3390/medicina58060756↗
- Paper Is surgical resection justified for pancreatic ductal adenocarcinoma with distant abdominal organ metastasis? A positio… DOI 10.1016/j.pan.2023.07.005↗
- Kęstutis Strupas · 3 shared papers, 2021–2022 · strength 0.52
- Paper The Impact of Epithelial-Mesenchymal Transition and Metformin on Pancreatic Cancer Chemoresistance: A Pathway towards I… DOI 10.3390/medicina58040467↗
- Paper Interdisciplinary Approach of Establishing PDAC Resectability: Biochemical, Radiological and NAT Regimen Prognostic Fac… DOI 10.3390/medicina58060756↗
- Paper Heat Shock Protein 90 Inhibitor Effects on Pancreatic Cancer Cell Cultures. DOI 10.1097/mpa.0000000000001807↗
- So Yamaki · 2 shared papers, 2023–2026 · strength 0.33
- Paper Survival Impact After Resection for Postoperative Recurrence or Metastasis of Pancreatic Ductal Adenocarcinoma Analyzed… DOI 10.1002/jhbp.70054↗
- Paper Is surgical resection justified for pancreatic ductal adenocarcinoma with distant abdominal organ metastasis? A positio… DOI 10.1016/j.pan.2023.07.005↗
- Atsushi Oba · 2 shared papers, 2023–2026 · strength 0.33
- Paper Survival Impact After Resection for Postoperative Recurrence or Metastasis of Pancreatic Ductal Adenocarcinoma Analyzed… DOI 10.1002/jhbp.70054↗
- Paper Is surgical resection justified for pancreatic ductal adenocarcinoma with distant abdominal organ metastasis? A positio… DOI 10.1016/j.pan.2023.07.005↗
- Axel Bengtsson · 1 shared paper, 2025 · strength 0.33
- Roland E. Andersson · 1 shared paper, 2025 · strength 0.33
- Daniel Ansari · 1 shared paper, 2025 · strength 0.33
- Denys Tsybulskyi · 1 shared paper, 2026 · strength 0.20
- Yosuke Inoue · 1 shared paper, 2026 · strength 0.20
- Teiichi Sugiura · 1 shared paper, 2026 · strength 0.20
- Kenjiro Okada · 1 shared paper, 2026 · strength 0.20
- Shoki Sato · 1 shared paper, 2026 · strength 0.20
- Ryuta Shintakuya · 1 shared paper, 2026 · strength 0.20
- Masamichi Mizuma · 1 shared paper, 2026 · strength 0.20
- Toshimichi Asano · 1 shared paper, 2026 · strength 0.20
- Kenichiro Uemura · 1 shared paper, 2026 · strength 0.20
- Daisuke Ban · 1 shared paper, 2026 · strength 0.20
- Katsuhisa Ohgi · 1 shared paper, 2026 · strength 0.20
- Nobuhiko Nakagawa · 1 shared paper, 2026 · strength 0.20
- Koetsu Inoue · 1 shared paper, 2026 · strength 0.20
- Michiaki Unno · 1 shared paper, 2026 · strength 0.20
- Satoshi Hirano · 1 shared paper, 2026 · strength 0.20
- Fuyuhiko Motoi · 1 shared paper, 2026 · strength 0.20
- Helena M. Kelly · 1 shared paper, 2022 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.